FDA: Page 81


  • Image attribution tooltip
    Adobe Stock
    Image attribution tooltip

    FDA finalizes IDE broadcasting guidance, with concessions to industry

    The final text is a major rewrite of a 2014 draft, which was criticized by AdvaMed.

    By July 11, 2019
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    FDA hits Clinicon with warning letter over sterility failings

    Inspectors found fault with the validation and calibration of processes and equipment involved in ensuring sterility of laser devices.

    By July 11, 2019
  • Boston Scientific's Farapulse pulsed field ablation device. Explore the Trendlineâž”
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    USTR exempts some medical devices from 25% China tariffs

    More decisions on pending requests for exemption will be made on a periodic basis, according to the U.S. Trade Representative.

    By David Lim • July 10, 2019
  • The 10 biggest medtech stories of Q2

    Key storylines — like escalating tariffs between the U.S. and China, FDA's evolving position on paclitaxel devices, and the uncertain capacity of Europe's notified bodies — will unfold in the second half of the year.

    By Maria Rachal • July 9, 2019
  • UL to close UK medical device notified body operation

    The notified body is stepping back from the U.K. device sector altogether and will limit its in vitro diagnostic services in response to the risk of a no-deal Brexit.

    By July 9, 2019
  • Sens. Warren, Murray probe FDA's 'alarming' progressive device approval idea

    The Democrats gave the agency until July 8 to respond to their questions on a recent budget proposal that seeks to grant FDA a two-step approval process for medical devices for life-threatening conditions.

    By David Lim • July 8, 2019
  • Spanish agency steps up to become an MDR notified body

    The decision comes as some in the sector have expressed concerns about whether there will be enough notified bodies to adequately support the transition to the EU's new medical device rules.

    By July 8, 2019
  • CMS extends ambulatory blood pressure monitoring coverage

    In a change, patients with masked hypertension will be eligible for testing.

    By July 3, 2019
  • FDA responds to feedback on De Novo classification requests

    The agency disagreed with many of the changes suggested in public comments on a draft guidance explaining acceptance review policies and procedures.  

    By July 2, 2019
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    FDA finalizes rule on requesting review of CDRH decisions

    The agency declined an AdvaMed request for additional time to seek supervisory review after a company receives details of a significant decision.

    By David Lim • July 2, 2019
  • Ruptured Edwards balloons linked to 3 patient deaths

    FDA revealed there have been 22 complaints related to rupture or puncture of an intra-aortic occlusion device, which can put patients at risk of complications like embolism, neurological damage and stroke.

    By July 2, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Trump: US won't impose tariffs on $300B Chinese goods 'for the time being'

    Existing 25% tariffs on $250 billion of Chinese goods, along with China's retaliatory tariffs, will remain in place.

    By Shefali Kapadia • June 29, 2019
  • FDA language on breast density info sharing inadequate, some mammography stakeholders say

    Memorial Sloan Kettering's breast imaging chief said a notification of higher risk may be "unduly alarming" to patients if providers aren't required to offer additional context and resources.

    By Maria Rachal • June 28, 2019
  • Health Canada to mandate medical device adverse event reporting

    The new regulations will force hospitals to report incidents within 30 days.

    By David Lim • June 27, 2019
  • The FDA logo on a glass pane at the agency's campus in Silver Spring, Maryland.
    Image attribution tooltip
    Jacob Bell/MedTech Dive
    Image attribution tooltip

    FDA finalizes guidance on diagnostic ultrasound systems

    The text hews closely to the draft the agency issued in 2017, the core of which detailed its policy on 510(k) filings.

    By June 27, 2019
  • Jejunostomy tube manufacturer draws FDA warning letter

    The agency reported a Colorado company had violations in the sterilization process for devices used for bowel decompression and lacked necessary procedures for evaluating its suppliers and inspecting finished products.

    By June 26, 2019
  • Image attribution tooltip
    Brian Tucker
    Image attribution tooltip
    Deep Dive

    Looming EPA ethylene oxide rules hang over device supply chain

    The medical device industry is lobbying Capitol Hill and statehouses, warning limited access to the sterilant could pose deadly disruptions.

    By David Lim • June 25, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Final TAVR Medicare decision gets thumbs up from Edwards, Medtronic

    The new policy eases volume requirements for hospitals and physicians to begin transcatheter aortic valve replacement programs but increases the number of valve procedures necessary to maintain a program.

    By June 24, 2019
  • FDA ends alternative reporting program, pledges to make MAUDE user friendly

    The agency disclosed more than 6 million medical device adverse event reports were filed under the controversial system since 1997. 

    By David Lim • June 24, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Label should warn patients of paclitaxel device mortality signal, FDA panel says

    The advisory committee struggled through the two-day meeting evaluating the safety of the devices due to incomplete data. Members agreed more data is needed but differed on the method the agency should use to collect it.

    By David Lim • June 21, 2019
  • SEC ends Misonix foreign corruption probe without action

    The maker of ultrasonic devices triggered the investigation in 2016 when it contacted the SEC with information about the business practices of its Chinese distributor.

    By June 21, 2019
  • FDA safety panel pans lack of paclitaxel device postmarket data on Day 1

    The agency's Circulatory System Devices Panel Advisory Committee agreed Wednesday there is a mortality signal associated with paclitaxel-coated balloons and paclitaxel-eluting stents.

    By David Lim • June 20, 2019
  • OIG finds Medicare overpaid $125M for radiation services

    The inspector general wants CMS to implement billing requirements and other changes intended to prevent further unnecessary payments.

    By June 20, 2019
  • Philips gets FDA approval for over-the-counter defibrillators

    The devices were previously cleared for sale in the U.S. via the 510(k) pathway but now need PMA approval.

    By June 20, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Foam to stop abdominal bleeding gets FDA breakthrough nod

    Gel-e's Life Foam product is designed to stabilize the patient in battlefield conditions or in a traumatic accident where life-threatening internal bleeding occurs and immediate urgent care isn't available.

    By June 19, 2019